Search details
1.
Pan-ebolavirus protective therapy by two multifunctional human antibodies.
Cell
; 184(22): 5593-5607.e18, 2021 10 28.
Article
in English
| MEDLINE | ID: mdl-34715022
2.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33667349
3.
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
Cell
; 184(5): 1188-1200.e19, 2021 03 04.
Article
in English
| MEDLINE | ID: mdl-33577765
4.
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
Cell
; 183(4): 1043-1057.e15, 2020 11 12.
Article
in English
| MEDLINE | ID: mdl-32970989
5.
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
Nat Immunol
; 23(6): 960-970, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35654851
6.
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
Cell
; 177(5): 1136-1152.e18, 2019 05 16.
Article
in English
| MEDLINE | ID: mdl-31100268
7.
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.
Cell
; 177(5): 1153-1171.e28, 2019 05 16.
Article
in English
| MEDLINE | ID: mdl-31080066
8.
Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Immunity
; 57(5): 1141-1159.e11, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38670113
9.
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface.
Immunity
; 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38823390
10.
Deception through Mimicry: A Cellular Antiviral Strategy.
Cell
; 175(7): 1728-1729, 2018 12 13.
Article
in English
| MEDLINE | ID: mdl-30550784
11.
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Cell
; 174(4): 938-952.e13, 2018 08 09.
Article
in English
| MEDLINE | ID: mdl-30096313
12.
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Immunity
; 56(8): 1927-1938.e8, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37506693
13.
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.
Cell
; 169(5): 891-904.e15, 2017 May 18.
Article
in English
| MEDLINE | ID: mdl-28525756
14.
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.
Cell
; 169(5): 878-890.e15, 2017 May 18.
Article
in English
| MEDLINE | ID: mdl-28525755
15.
Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.
Immunity
; 55(9): 1693-1709.e8, 2022 09 13.
Article
in English
| MEDLINE | ID: mdl-35952670
16.
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice.
Immunity
; 55(11): 2168-2186.e6, 2022 11 08.
Article
in English
| MEDLINE | ID: mdl-36179690
17.
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses.
Immunity
; 55(10): 1856-1871.e6, 2022 10 11.
Article
in English
| MEDLINE | ID: mdl-35987201
18.
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.
Immunity
; 55(11): 2149-2167.e9, 2022 11 08.
Article
in English
| MEDLINE | ID: mdl-36179689
19.
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.
Cell
; 164(3): 392-405, 2016 Jan 28.
Article
in English
| MEDLINE | ID: mdl-26806128
20.
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
Cell
; 166(6): 1459-1470.e11, 2016 Sep 08.
Article
in English
| MEDLINE | ID: mdl-27610570